NYXH (Nyxoah SA Ordinary Shares) Stock Analysis

Nyxoah SA Ordinary Shares (NYXH) is a publicly traded Healthcare sector company. As of May 21, 2026, NYXH trades at $2.99 with a market cap of $127.49M and a P/E ratio of 0.00. NYXH moved +2.14% today. Year to date, NYXH is -39.15%; over the trailing twelve months it is -62.86%. Its 52-week range spans $2.72 to $11.87. Analyst consensus is buy with an average price target of $7.96. Rallies surfaces NYXH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest NYXH stock research?

Nyxoah SA Ordinary Shares (NYXH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NYXH moved +2.14% today. Analyst consensus is buy.

NYXH Key Metrics

Key financial metrics for NYXH
MetricValue
Price$2.99
Market Cap$127.49M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$11.87
52-Week Low$2.72
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest NYXH News

NYXH Analyst Consensus

6 analysts cover NYXH: 0 strong buy, 3 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.96.

Common questions about NYXH

What can I research for NYXH on Rallies?
Nyxoah SA Ordinary Shares (NYXH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NYXH moved +2.14% today. Analyst consensus is buy.
Does Rallies show live market data for NYXH?
Rallies combines live market context with ticker research for NYXH, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
NYXH

NYXH